Activation of FXR by obeticholic acid (OCA) increased insulin sensitivity and reduced markers of liver inflammation and fibrosis in patients with type 2 diabetes and NAFLD16. The gene discussed is NR1H4; the disease is type 2 diabetes mellitus.